Media

A collection of webinars and educational media content designed to keep you up to speed.

The State of Fentanyl and Opioids: 2024


In this live recorded webinar, we delve into the pressing topic of Fentanyl, other Opioids, usage, myths and the current state of the ongoing opioid crisis. Our Chief Product Officer, Eric Malis, will provide insights into these substances, including their impact on public health, trends in usage, regulatory measures, and innovative approaches to address the crisis. From the latest statistics to potential solutions, this webinar promises a comprehensive exploration of one of today’s most urgent public health challenges.

Exploring Hallucinogens: Mind-Altering Realities and Approaches to Testing

In this insightful live recorded webinar, we delve into the world of hallucinogens from a point of care toxicology testing standpoint. We will explore various types of hallucinogens, their effects on the mind and body, and the challenges they present in regard to toxicology screening. Our Chief Product Officer, Eric Malis, will discuss current testing methods, limitations, and future advancements in this field. Whether you’re a healthcare professional, researcher, or simply have an interest in the subject, this webinar promises to provide valuable knowledge and perspective.

Opiates and Opioids: Breaking Down the Differences

Chief Product Officer, Eric Malis, discusses Opiates and Opioids and the differences between them. Often the two are thought to be one in the same but there is important information you need to know about what makes them different and what that means from a drug testing stand point.

Benzodiazepine: Important Information About the Often-Abused Depressant

Benzodiazepines, most commonly known as the prescription drugs, Xanax®, Valium®, Halcion®, Ativan® and Klonopin®, can be very helpful to those who need it. Unfortunately this medication has a high risk of dependency and can lead to abuse. Join our Chief Product Officer, Eric Malis, for another LIVE  recorded educational webinar about the commonly prescribed yet commonly abused depressant. Learn about the importance and dangers of Benzodiazepine and how and why you should be testing for it.

Xylazine: An Emerging Threat and What You Need to Know

Most of us have probably heard something in the news about Xylazine. The powerful veterinary sedative and anesthetic, often referred to as “Tranq” on the street, is becoming more commonly abused across the US. In this recorded live session, Chief Product Officer, Eric Malis, will talk about why this is important, things you should know, and what you can do to detect use and help fight this new emerging threat. 

State of Designer Opioids

The state of designer opioids is an ever changing landscape. When it comes to powerful street drugs such as designer opioids it is important to understand what is being produced and what to look out for. Chief Product Officer takes a deep dive into understanding current trends of designer opioids.

Adulterant Demonstration

Adulteration is an issue that most have encountered at one time or another in drugs of abuse management programs. Patients, or donors, sometimes go to great lengths to adulterate a specimen in an attempt to avoid a positive test result. In this video, Chief Product Officer, Eric Malis, discusses the importance of using and reading adulteration test strips correctly along with a hands on demonstration.

Gas Station Dope

In the latest NTS-U Webinar, join Chief Product Office, Eric Malis in discussing drugs of abuse commonly found at gas stations, convenience stores, and smoke shops; most of which are in legal gray areas. 

Contact us

Call Us

1-866-989-9300

Email Us

info@ntsbiz.com

Our Location

550 NW 77th Street

Boca Raton, FL 33487

Get in touch